this 👇 $UNT just levelled up with ISO27001 certification secured the gold standard for info‑security. This is the ticket needed for banks, gov, and large‑enterprise deals. Strong signal they’re building for scale.
The market panicked over short-term dilution, completely mispricing the structural unlock for $LDX.AX. A recent FDA CLIA waiver didn't just expand their diagnostic TAM 15-fold—it activated a guaranteed $317M revenue floor. With the stock trading at a severe discount to its contracted minimums, this is one of the most asymmetric risk/reward setups in the market right now. Here is why the current valuation is a mathematical mismatch. 🔬 #MedTech #Microcap
https://t.co/oCmqHp5GzA
Lumos Diagnostics Holdings Limited $LDX.AX recently secured a pivotal FDA CLIA waiver for its FebriDx rapid blood test, expanding its addressable US market fifteen-fold to over 300,000 outpatient locations. This crucial regulatory milestone activated an exclusive distribution agreement with PHASE Scientific, locking in a massive $317 million minimum contract value to securely de-risk the company's commercial rollout. Armed with a recent equity placement that boosted its pro-forma cash balance to $26.1 million, the business is now fully funded to scale manufacturing capacity ahead of the upcoming flu season. Analysts highlight an asymmetric risk-reward profile with a base-case price target representing over 200 percent upside as the firm transitions into generating high-margin, recurring commercial revenue. Will the rapid test's clinical utility and dedicated reimbursement codes be enough to drive widespread adoption among primary care providers accustomed to traditional laboratory testing?
$LDX | #Lumos has released a U.S. rollout update for FebriDx® following FDA CLIA waiver clearance, with encouraging early implementation and reimbursement indicators as the Company builds momentum ahead of the 2026/27 flu season. Read the announcement:
https://t.co/a9IOq1edrp
$PVT Horden Lake ; Latest JORC MRE 37Mt @ 1.1% CuEq→407kt CuEq contained. Pit constrained: 341kt CuEq in ONE shallow open pit shell~200kt Cu in-pit. Leading shallow high-grade Cu play on ASX. Ore sorting just 2.1x grade uplift ; should be significant upside here
$PVT Cheapest copper play on the #ASX Horden Lake (37Mt @1.1% CuEq) alone fall nets the current $18M mcap. Belleterre high-grade Cu-Ni-PGM assays incoming
$PVT
$PVT to start exploration program at LaForce #Copper & #Nickel target
Historical results such as 102.7M at 0.39% #Copper & 0.76% #Nickel from 1.3M
Drilling continuing at Belleterre prospects with first assays due end of May!
MRE upgrade for Horden Lake due this quarter!
#Speculation
Been an interesting time in the markets for me lately
#Copper & #Silver looking strong & keep going higher while my #Copper & #Silver stocks such as #GG1 $PVT $LDR & $TAT go lower 😂
They all have cash, resources & drilling with low MCs
I think it changes soon!
$PVT
#Copper making new all time highs!
$PVT sitting on 37Mt at 1.1% #Copper eq mostly shallow pit constrained in Quebec!
MRE upgrade due around end of the month!
17M MC with 4.4M cash
🤔
⬇️⬇️